13D Filing: Meridian OHC Partners Gunning for Board Seat at Infusystem Holdings, Inc (INFU)

We have a fresh 13D filing embedded below and on the coming pages, issued by Meridian OHC Partners. The filing, on InfuSystem Holdings Inc (NYSEMKT:INFU), reveals the investor’s most up-to-date investment position in the stock, which includes ownership of 2.45 million shares. The filing also reveals that Meridian OHC’s Scott Shuda has expressed to the company a desire to be added to its Board of Directors. Be sure to check out the ownership table below, as well as the filing itself for all of the details.

You can access the original SEC filing by clicking here.

Ownership Summary Table

Name Sole Voting Power Shared Voting Power Sole Dispositive Power Shared Dispositive Power Aggregate Amount Owned Power Percent of Class
Meridian OHC Partners, 0 2,340,276 0 2,340,276 2,451,972 10.9%
Meridian TSV II, 0 14,028 0 2,340,276 2,451,972 10.9%
TSV Investment Partners, 0 2,354,304 0 2,354,304 2,451,972 10.9%
BlueLine Capital Partners II, 0 97,668 0 97,668 2,451,972 10.9%
BlueLine Partners, 0 97,668 0 97,668 2,451,972 10.9%

Page 1 of 9 SEC Filing


UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
SCHEDULE 13D
Under the Securities Exchange Act of 1934
(Amendment No. ________)*
InfuSystem Holdings, Inc.
(Name of Issuer)
Common Stock,
par value $0.0001 per share
(Title of Class of Securities)
45685K102 (CUSIP Number)
Scott A Shuda
Meridian OHC Partners, LP
425 Weed Street
New Canaan, CT 06840
(Name, Address and Telephone Number of Person
Authorized to Receive Notices and Communications)
February 11, 2016
(Date of Event which Requires Filing of this Statement)
If the filing person has previously filed a statement on Schedule 13G to report the acquisition that is the subject of this Schedule 13D, and is filing this schedule because of §§240.13d-1(e), 240.13d-1(f) or 240.13d-1(g), check the following box.
Note: Schedules filed in paper format shall include a signed original and five copies of the schedule, including all exhibits. See §240.13d-7 for other parties to whom copies are to be sent.
* The remainder of this cover page shall be filled out for a reporting person’s initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter disclosures provided in a prior cover page.
The information required on the remainder of this cover page shall not be deemed to be “filed” for the purpose of Section 18 of the Securities Exchange Act of 1934 (“Act”) or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes).
Follow Infusystem Holdings Inc (NYSEMKT:INFU)